Accurate identification of positive lymph nodes in men with progressive prostate cancer

One of the hardest things to be able to do, currently, in a man with progressive prostate cancer after first- or second-line therapy, is to determine his risk for lymph node-positive prostate cancer or LNPPC (i.e., one of the earliest  and more common components of metastatic prostate cancer). … READ MORE …

PPC as a key element of clinical stage instead of T stage in localized prostate cancer?

In recent years it has become increasingly widely accepted that clinical stage is of dubious value as a prognostic factor in determining prostate cancer risk, particularly as regards the sub-stages of clinical stage T2 (i.e., T2a, T2b, and T2c) in men with localized prostate cancer. … READ MORE …

Adjuvant radiation + ADT after surgery for SV+ prostate cancer

A new study just published in BJU International offers data suggesting the idea that all men found to have positive seminal vesicles (SV+) after radical prostatectomy should receive immediate adjuvant treatment with external beam radiation and  androgen deprivation therapy (ADT). … READ MORE …

Immediate adjuvant therapy for men with positive surgical margins after RP

There are no absolute guidelines as to which patients who have positive surgical margins after a radical prostatectomy (RP) are most appropriate for immediate adjuvant radiation therapy (with or without neoadjuvant and/or adjuvant hormone therapy). … READ MORE …

What’s hot at the AUA annual meeting (Sunday morning)?

So lots of posters and and presentations this morning, but not a lot of actionable information for patients (as far a we could tell). Among the more interesting papers were the following: … READ MORE …

Post-surgical outcomes of men with positive seminal vesicles over time

An interesting research question is whether, given the earlier diagnosis, the reduced risk for positive surgical margins, and the reduced likelihood of positive lymph nodes at the time of diagnosis in the contemporary PSA era, there has been any impact on the long-term outcomes of men with pathologic T3b prostate cancer post-surgery. … READ MORE …

Prostate weight and risk for positive margins at surgery

A new study has clearly shown that men with lighter (and therefore smaller) prostates are at greater risk for positive surgical margins after robot-assisted laparoscopic prostatectomy (RALP) than men with heavier (and therefore larger) prostates. … READ MORE …

PCA3, PSA, and free PSA in prediction of prostate cancer risk

A new study has suggested that, although the PCA3 test is slightly better than the total PSA test in prediction of risk for a positive biopsy finding, it is not necessarily always better than the free PSA test. … READ MORE …

How many biopsy cores is the “right” number? (revised and revisited)

The current report offers a revised and updated commentary on the paper by Abd et al., first referred to yesterday on this blog. We have now had the opportunity to read the entire paper. While it does not change the general tenor of our prior comments, it is useful to make sure one has all relevant information on a topic this important. … READ MORE …

The continuing saga of the value of PSA velocity

An analysis of data from the Rotterdam and Göteborg subsets of men enrolled in the European Randomized Screening for Prostate Cancer (ERSPC) study suggests that PSA velocity is of little value in the identification of men who would benefit from a second biopsy after a first, negative biopsy. … READ MORE …

Positive surgical margins — “déja vu all over again”

It is educational to compare the data from the Mayo Clinic, published just the other day, with data just reported by the University of Michigan, which show a clear association between the presence of positive surgical margins and disease-free patient survival in prostate cancer patients. … READ MORE …

Surgery for lymph node-positive prostate cancer: a second look

For many years, the urology group at the Mayo Clinic has argued that surgery is a viable form of treatment for at least some patients with TxN+M0 prostate cancer. A retrospective analysis of data from the Munich Cancer Registry in Germany now seems to confirm this argument. … READ MORE …

What does a positive surgical margin actually predict after surgery?

Maybe 20-30 percent of all prostate cancer patients will be told, today, after a radical prostatectomy, that they a have a positive surgical margin. But exactly what impact a positive surgical margin has on a patient’s risk for disease recurrence has never been very clear. … READ MORE …

Radiation therapy in patients with +ve surgical margins

This month’s issue of AUA News carries two articles espousing different opinions about the appropriate use and timing of radiation therapy for prostate cancer patients who have positive surgical margins after an initial radical prostatectomy. … READ MORE …

Is a PSM an independent predictor of risk for disease progression?

A study just published by Sæther et al. appears to suggest that the clinical finding of a positive surgical margin (PSM) is not an important independent predictor for risk of progression when compared to other data available at the time of surgery. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 827 other followers